Abstract: Various methods and systems are provided for monitoring and displaying a patient status. In one example, the patient monitoring system includes a display device configured to display a patient status view include on or more multidimensional plots overlaying more than one of real time values, historical values, and upper and lower threshold values for a plurality of patient parameters, and additionally being configured to display an abbreviated representation of the one or more multidimensional plots that can be reached directly from the patient status view. The abbreviated representation is displayed in an unlaunched state, and displays a limited version of the respective multidimensional plot and is selectable to launch and enable the respective multidimensional plot to be seen.

Abstract: A method of monitoring depth of muscle relaxation of a patient includes determining a sedative drug effect of one or more sedative drugs on a patient based on at least one of drug delivery information and measured nervous system information. The sedative drug effect is then compared to a sedation criterion and, if the sedative drug effect fulfills the sedation criterion, then a neuromuscular transmission (NMT) monitor is controlled to apply a series of stimulation to a nerve of a patient and muscle responses of the patient are measured to obtain an NMT baseline. A neuromuscular blocking agent (NMBA) notice is then generated on a user interface after obtaining the NMT baseline.

Abstract: A method of monitoring depth of muscle relaxation of a patient includes determining a sedative drug effect of one or more sedative drugs on a patient based on at least one of drug delivery information and measured nervous system information. The sedative drug effect is then compared to a sedation criterion and, if the sedative drug effect fulfills the sedation criterion, then a neuromuscular transmission (NMT) monitor is controlled to apply a series of stimulation to a nerve of a patient and muscle responses of the patient are measured to obtain an NMT baseline. A neuromuscular blocking agent (NMBA) notice is then generated on a user interface after obtaining the NMT baseline.